Skip to content
The Policy VaultThe Policy Vault

Inlyta (axitinib tablets - Pfizer) — Cigna

Renal cell carcinoma (relapsed or advanced)

Initial criteria

  • Patient is age ≥ 18 years
  • Patient has relapsed or advanced disease

Approval duration

1 year